Arkolith/Insider Trading/RPRX/Form 4

Hite Christopher

EVP & Chairman, PartneringRoyalty Pharma plc (RPRX) · full profile →Form 4 · filed Aug 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.0M
Net Open-Market Flow
-$6.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 19, 2026Gift(G)17K—$023K
Aug 18, 2026Sell(S)100K$59.97$6.0M370K

Transaction Codes

G
Gift
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001814238-26-000015) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Royalty Pharma plc

Build

Ask your agent about RPRX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001814238-26-000015"
Ask your agent
Use Arkolith to summarize insider buying and selling at Royalty Pharma plc
over the last 90 days and cite the filings.